Editas Medicine, Inc.EDITNASDAQ
Loading
Revenue minus cost of goods sold
3Y CAGR
+44.7%/yr
Annual compound
Percentile
P92
Near historical high
vs 3Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $40.52M | +25.4% |
| 2024 | $32.31M | -55.2% |
| 2023 | $72.06M | +438.8% |
| 2022 | $13.38M | -34.7% |
| 2021 | $20.49M | +130.5% |
| 2020 | $-67.26M | +11.9% |
| 2019 | $-76.37M | -30.1% |
| 2018 | $-58.72M | +15.4% |
| 2017 | $-69.43M | -36.3% |
| 2016 | $-50.93M | - |